China approves home-grown vaccines, offering alternative to global drugmakers' products

China has approved a pneumonia vaccine developed by Chinese drugmaker Walvax Biotechnology's unit, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to one of Pfizer's best-selling products Prevnar 13.